Kopran Share Price

Name: Kopran
Brand: Kopran

Pharmaceuticals Small Cap

₹309.₈₀ +18.65 (6.41%)

05 Nov, 2024 21:06

Start SIP in KOPRAN

Start SIP

Performance

Low
₹289

High
₹314

52 Week Low
₹198

52 Week High
₹370

Open Price₹291
Previous Close₹291
Volume1,224,624

Investment Returns

Over 1 Month -1.16%
Over 3 Month + 21.21%
Over 6 Month + 24.02%
Over 1 Year + 35.55%

Smart Investing Starts Here Start SIP with Kopran for Steady Growth!

Invest Now

Kopran Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

P/E Ratio
25.2

PEG Ratio
0.2

Market Cap Cr
1,495

P/B Ratio
3

Average True Range
15.87

Dividend Yield
1

MACD Signal
-6.8

RSI
55.38

MFI
58.49

Standalone Consolidated

Indicator	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Net Sales/Income from operations	49.61	90.62	82.33	98.64	65.86
Total Income From Operations	49.61	90.62	82.33	98.64	65.86
P/L Before Interest, Excpt. Items & Tax	6.20	22.33	12.18	13.33	1.18
P/L Before Exceptional Items & Tax	5.51	20.55	11.16	12.58	0.23
P/L After Tax from Ordinary Activities	4.25	15.31	8.51	10.66	0.15
Net Profit/Loss For the Period	4.25	15.31	8.51	10.66	0.15

Indicator	Mar 24	Mar 23
Revenue From Operations [Gross]	331.49	268.89
Revenue From Operations [Net]	331.49	268.89
Total Operating Revenues	337.46	273.09
Total Revenue	354.17	289.18
Total Expenses	309.65	252.27
Profit/Loss Before Tax	44.52	36.92
Profit/Loss For The Period	34.64	31.25

Indicator	Mar 24	Mar 23
Net CashFlow - Operating Activity	34.96	16.87
Net Cash Used In Investing Activity	-6.27	10.05
Net Cash Used in Finance Activity	-24.08	-26.13
Net Inc/Dec In Cash And Equivalent	4.61	0.79
Cash And Equivalent End Of Year	5.65	1.04

Indicator	Mar 24	Mar 23
Total Share Capital	48.21	48.21
Total Non-Current Liabilities	9.47	9.48
Total Current Liabilities	84.54	100.88
Total Capital And Liabilities	510.88	505.95
Total Non-Current Assets	323.17	315.54
Total Current Assets	187.70	190.41
Total Assets	510.88	505.95

Indicator	2024	2023
EBIT Margin (%)	14.52	14.49
Return On Capital Employed (%)	11.49	9.77
Return On Equity (%)	8.30	7.90
Long Term Debt To Equity (%)	0.53	0.58
Book Value/Share (INR)	86.47	82.05

Indicator	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Net Sales/Income from operations	139.44	186.08	158.92	152.59	117.00
Total Income From Operations	139.44	186.08	158.92	152.59	117.00
P/L Before Interest, Excpt. Items & Tax	16.92	27.76	22.74	20.19	5.44
P/L Before Exceptional Items & Tax	14.73	25.18	20.51	18.25	3.61
P/L After Tax from Ordinary Activities	11.10	18.62	15.79	13.77	2.77
Net Profit/Loss For the Period	11.10	18.62	15.79	13.77	2.77

Indicator	Mar 24	Mar 23
Revenue From Operations [Gross]	610.09	548.18
Revenue From Operations [Net]	610.09	548.18
Total Operating Revenues	614.59	550.99
Total Revenue	629.20	554.05
Total Expenses	561.66	517.99
Profit/Loss Before Tax	67.54	36.07
Profit/Loss For The Period	50.96	27.23

Indicator	Mar 24	Mar 23
Net CashFlow - Operating Activity	43.26	34.02
Net Cash Used In Investing Activity	-43.55	-12.65
Net Cash Used in Finance Activity	0.99	-19.84
Net Inc/Dec In Cash And Equivalent	0.69	1.53
Cash And Equivalent End Of Year	8.09	7.40

Indicator	Mar 24	Mar 23
Total Share Capital	48.21	48.21
Total Non-Current Liabilities	33.47	33.48
Total Current Liabilities	218.53	176.97
Total Capital And Liabilities	743.25	649.70
Total Non-Current Assets	289.22	250.63
Total Current Assets	454.03	399.07
Total Assets	743.25	649.70

Indicator	2024	2023
EBIT Margin (%)	12.38	7.64
Return On Capital Employed (%)	14.51	8.91
Return On Equity (%)	10.37	6.19
Long Term Debt To Equity (%)	3.37	4.07
Book Value/Share (INR)	101.90	91.11

Kopran Technicals

EMA & SMA

Current Price

₹309.₈₀

+ 18.65 (6.41%)

Bullish Moving Average 15

Bearish Moving Average 1

EMA SMA

20 Day
₹297.69

50 Day
₹300.84

100 Day
₹291.40

200 Day
₹273.44

Resistance and Support

303.97

R3 344.53
R2 329.07
R1 319.43

S1 294.33
S2 278.87
S3 269.23

Is Kopran Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Kopran Ltd. is a fully integrated pharmaceutical company, engaged in the manufacturing and marketing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company serves global markets with a focus on innovation, quality, and regulatory compliance. Kopran has an operating revenue of Rs. 637.03 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 11% is healthy, ROE of 10% is good. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 6% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 88 which is a GOOD score indicating consistency in earnings, a RS Rating of 60 which is FAIR indicating the recent price performance, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 35 indicates it belongs to a strong industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Kopran Corporate Actions - Bonus, Splits, Dividends

Board

Date	Purpose	Remarks
2024-08-08	Quarterly Results
2024-05-16	Audited Results & Final Dividend
2024-02-07	Quarterly Results
2023-11-07	Quarterly Results
2023-08-10	Quarterly Results

Kopran F&O

Kopran Shareholding Pattern

Sep 24
Jun 24
Mar 24
Dec 23

Promoters
Mutual Funds
Insurance Companies
Foreign Portfolio Investors
Financial Institutions/ Banks
Individual Investors
Others

Promoters

44.49%

Mutual Funds

Insurance Companies

Foreign Portfolio Investors

1.31%

Financial Institutions/ Banks

Individual Investors

40.75%

Others

13.45%

NSE Symbol
KOPRAN

BSE Symbol
524280

ISIN
INE082A01010

Start Investing in 5* minutes

+91

By proceeding, you agree to our T&Cs*

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

Kopran Share Price

₹309.₈₀ +18.65 (6.41%)

Performance

Investment Returns

Smart Investing Starts Here Start SIP with Kopran for Steady Growth!

Kopran Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Kopran Financial

Kopran Technicals

EMA & SMA

Resistance and Support

Is Kopran Worth Buying?

Ratings

Kopran Corporate Actions - Bonus, Splits, Dividends

Kopran F&O

Kopran Shareholding Pattern

Kopran FAQs

What is Share Price of Kopran ?

What is the Market Cap of Kopran ?

What is the P/E ratio of Kopran ?

What is the PB ratio of Kopran ?

Start Investing in 5* minutes

Kopran Share Price

₹309.80 +18.65 (6.41%)

Performance

Investment Returns

Smart Investing Starts Here Start SIP with Kopran for Steady Growth!

Kopran Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Kopran Financial

Kopran Technicals

EMA & SMA

Resistance and Support

Is Kopran Worth Buying?

Ratings

Kopran Corporate Actions - Bonus, Splits, Dividends

Kopran F&O

Kopran Shareholding Pattern

Kopran FAQs

What is Share Price of Kopran ?

What is the Market Cap of Kopran ?

What is the P/E ratio of Kopran ?

What is the PB ratio of Kopran ?

Start Investing in 5* minutes

₹309.₈₀ +18.65 (6.41%)